Buscar
Mostrando ítems 1-10 de 48
The pharmacological treatment of obesity: A historical perspective
(Academia Nacional de Medicina venezolana., 2022)
Insights into the Molecular Requirements for the Anti-obesity Activity of a Series of CB1 Ligands
(WILEY-BLACKWELL, 2010)
Two-dimensional and 3D quantitative structure-activity relationships studies were performed on a series of diarylpyridines that acts as cannabinoid receptor ligands by means of hologram quantitative structure-activity ...
Tratamiento farmacológico o quirúrgico del paciente con sobrepeso u obesidad
(Sociedad Médica de Santiago, 2009)
Encapsulated peptides and proteins with an effect on fatiety
(Nanomaterials, 2023)
Encapsulated peptides and proteins with an effect on satiety
(Nanomaterials, 2023)
Emerging drugs for obesity therapy
(Sociedade Brasileira de Endocrinologia e Metabologia, 2009-03-01)
Central obesity have an important impact on the development of risk factors for coronary heart disease, including dislipidemia, glucose intolerance, insulin resistance and hypertension. These factors contribute to building ...
Statement about the medical and surgical treatment of overweight and obesity Tratamiento farmacológico o quirúrgico del paciente con sobrepeso u obesidad
(2009)
This is an updated review of the available treatments for obesity, that can be used when lifestyles modifications fail. Using the available information and the experience of the members of this advisory group, a recommendation ...
Oxintomodulina e obesidade
(Pontifícia Universidade Católica de Campinas, 2009-10-01)
Since the discovery of leptin, great advances occurred in the characterization of hypothalamic mechanisms involved in the control of food intake and oxyntomodulin is currently recognized as a homeostasis energy regulator. ...